Inhibition of tumor necrosis factor-α-dependent cardiomyocyte apoptosis by metallothionein

Cardiovascular Toxicology

Volumn 2, Issue 3, 2002, Pages 209-217

  Klein, Jon B ^a   Wang, Guang Wu ^a   Zhou, Zhanxiang ^a   Buridi, Abdul ^a   Kang, Y James ^a,b  

^a University of Louisville School of Medicine   (United States)

^b UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

Antioxidant; Cell death; Oxidative stress; p38 MAPK; Reactive oxygen species; TUNEL

Indexed keywords

ISOTHIOCYANIC ACID; LIPOCORTIN 5; METALLOTHIONEIN; MITOGEN ACTIVATED PROTEIN KINASE; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA; MITOGEN ACTIVATED PROTEIN KINASE P38;

ANIMAL CELL; ANTIGEN ANTIBODY COMPLEX; APOPTOSIS; ARTICLE; CELL CULTURE; CELL ISOLATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME PHOSPHORYLATION; GENE OVEREXPRESSION; HEART MUSCLE CELL; MOUSE; NEWBORN; NICK END LABELING; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN FUNCTION; STAINING; TRANSGENIC MOUSE; WILD TYPE; ANIMAL; BIOSYNTHESIS; COMPARATIVE STUDY; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; GENETICS; METABOLISM; PHYSIOLOGY;

ANIMALIA; MUS MUSCULUS;

ANIMALS; APOPTOSIS; CELLS, CULTURED; METALLOTHIONEIN; MICE; MICE, TRANSGENIC; MITOGEN-ACTIVATED PROTEIN KINASES; MYOCYTES, CARDIAC; P38 MITOGEN-ACTIVATED PROTEIN KINASES; REACTIVE OXYGEN SPECIES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0038506234     PISSN: 15307905     EISSN: None     Source Type: Journal    
DOI: 10.1385/CT:2:3:209     Document Type: Article

References (31)

1. Grossman, G.B., Rohde, L.E., and Clausell, N. (2001). Evidence for increased peripheral production of tumor necrosis factor-alpha in advanced congestive heart failure. Am. J. Cardiol. 88:578-581.
2. Gottlieb, E., Vander Heiden, M.G., and Thompson, C.B. (2000). Bcl-x(L) prevents the initial decrease in mitochondrial membrane potential and subsequent reactive oxygen species production during tumor necrosis factor alpha-induced apoptosis. Mol. Cell. Biol. 20:5680-5689.
3. Kang, Y.J., Chen, Y., Yu, A., et al. (1997). Overexpression of metallothionein in the heart of transgenic mice suppresses doxorubicin cardiotoxicity. J. Clin. Invest. 100:1501-1506.
4. Kang, Y.J. (1999). The antioxidant function of metallothionein in the heart. Proc. Soc. Exp. Biol. Med. 222:263-273.
5. Sun, X., Zhou, Z. and Kang, Y.J. (2001). Attenuation of doxorubicin chronic toxicity in metallothionein-overexpressing transgenic mouse heart. Cancer Res. 61:3382-3387.
6. Kang, Y.J., Li, G., and Saari, J.T. (1999). Metallothionein inhibits ischemia-reperfusion injury in mouse heart. Am. J. Physiol. 276(3 Pt. 2):H993-H997.
7. Wang, G.W., Schuschke, D.A., and Kang, Y.J. (1999). Metallothionein-overexpressing neonatal mouse cardiomyocytes are resistant to H2O2 toxicity. Am. J. Physiol. 276(1 Pt. 2):H167-H175.
8. Wang, G.W. and Kang, Y.J. (1999). Inhibition of doxorubicin toxicity in cultured neonatal mouse cardiomyocytes with elevated metallothionein levels. J. Pharmacol. Exp. Ther. 288:938-944.
9. Kang, Y.J., Zhou, Z.X., Wang, G.W., et al. (2000). Suppression by metallothionein of doxorubicin-induced cardiomyocyte apoptosis through inhibition of p38 mitogen-activated protein kinases. J. Biol. Chem. 275:13,690-13,698.
10. Karbowski, M., Kurono, C., Woznak, M., et al. (1999). Free radical-induced megamitochondria formation and apoptosis. Free. Radical Biol. Med. 26:396-409.
11. LeBel,, C.P., Ishiropoulos, H., and Bondy, S.C. (1992). Evaluation of the probe 2′,7′-dicholorofluorescein as an indicator of reactive oxygen species formation and oxidative stress. Chem. Res. Toxicol. 5:227-231.
12. Garland, J.M. and Halestrap, A. (1997). Energy metabolism during apoptosis: bcl-2 promotes survival in hematopoietic cells induced to apoptosis by growth factor withdrawal by stabilizing a form of metabolic arrest. J. Biol. Chem. 272:4680-4688.
13. Wang, Y., Huang, S., Sah, V.P., et al. (1998). Cardiac muscle cell hypertrophy and apoptosis induced by distinct members of the p38 mitogen-activated protein kinase family. J. Biol. Chem. 273:2161-2168.
14. Jiang, Y., Chen, C., Li, Z., et al. (1996). Characterization of the structure and function of a new mitogen-activated protein kinase (p38). J. Biol. Chem. 271:17,920-17,926.
15. Lee, J.C., Laydon, J.T., McDonnell, P.C., et al. (1994). A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 372:739-746.
16. Lechner, C., Zahalka, M.A., Giot, J.F., et al. (1996). ERK6, a mitogen-activated protein kinase involved in C2C12 myoblast differentiation. Proc. Natl. Acad. Sci. USA. 93:4355-4359.
17. Cuenda, A., Rouse, J., Doza, Y.N., et al. (1995). SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Lett. 364:229-233.
18. Wang, X.S., Diener, K., Jannuzzi, D., et al. (1996). Molecular cloning and characterization of a novel protein kinase with a catalytic domain homologous to mitogen-activated protein kinase kinase kinase. J. Biol. Chem. 271:31,607-31,611.
19. Rane, M.J., Carrithers, S.L., Arthur, J.M., et al. (1997). Formyl peptide receptors are coupled to multiple mitogen-activated protein kinase cascades by distinct signal transduction pathways: role in activation of reduced nicotinamide adenine dinucleotide oxidase. J. Immunol. 159:5070-5078.
20. Yamashita, N., Nishida, M., Hoshida, S., et al. (1994). Induction of manganese superoxide dismutase in rat cardiac myocytes increases tolerance to hypoxia 24 hours after preconditioning. J. Clin. Invest. 94:2193-2199.
21. Wang, X.Z. and Ron, D. (1996). Stress-induced phosphorylation and activation of the transcription factor CHOP (GADD153) by p38 MAP kinase. Science 272:1347-1349.
22. Tan, Y., Rouse, J., Zhang, A., et al. (1996). FGF and stress regulate CREB and ATF-1 via a pathway involving p38 MAP kinase and MAPKAP kinase-2. EMBO J. 15:4629-4642.
23. Lin, Q., Schwarz, J., Bucana, C., et al. (1997). Control of mouse cardiac morphogenesis and myogenesis by transcription factor MEF2C. Science 276:1404-1407.
24. Yin, T., Sandhu, G., Wolfgang, C.D., et al. (1997). Tissue-specific pattern of stress kinase activation in ischemic/reperfused heart and kidney. J. Biol. Chem. 272:19,943-19,950.
25. Craig, R., Larkin A., Mongo, A.M., et al. (2000). p38 MAPK and NF-κB collaborate to induced interleukin-6 gene expression and release. J. Biol. Chem. 375:23,814-23,824.
26. Zechner, D., Craig, R., Hanford, D.S., et al. (1998). MKK6 activates myocardial cell NF-κB and inhibits apoptosis in a p38 mitogen-activated protein kninase-dependent manner. J. Biol. Chem. 373:8232-8239.
27. Sabbah N.N. and Sharov, V.G. (1998). Apoptosis in heart failure. Prog. Cardiovasc. Dis. 40:549-562.
28. Jacob, C., Maret, W., and Vallee, B.L. (1998). Control of zinc transfer between thionein, metallothionein, and zinc proteins. Proc. Natl. Acad. Sci. USA 95:3489-3494.
29. Aiuchi, T., Mihara, S., Nakaya, M., et al. (1998). Zinc ions prevent processing ofcaspase-3 during apoptosis induced by geranylgeraniol in HL-60 cells. J. Biochem. (Tokyo) 124:300-303.
30. Meerarani, P., Ramadass, P., Toborek, M., et al. (2000). Zinc protects against apoptosis of endothelial cells induced by linoleic acid and tumor necrosis factor alpha. Am. J. Clin. Nutr. 71:81-87.
31. Vallee, B.L. and Falchuk, K.H. (1993). The biochemical basis of zinc physiology. Physiol. Rev. 73:79-118.